Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Pulse Biosciences, Inc (PLSE) had Weighted-Average Shares Outstanding (Diluted) of 67.13M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-16.80M |
|
-- |
|
-- |
|
$18.04M |
|
$-18.04M |
|
$1.25M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-16.80M |
|
$-18.04M |
|
$-17.76M |
|
67.13M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
67.13M |
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$120.91M |
|
$1.06M |
|
$12.47M |
|
$133.38M |
|
$7.76M |
|
-- |
|
$7.17M |
|
$14.93M |
|
$118.45M |
|
$114.61M |
|
$118.45M |
|
67.27M |
|
| Cash Flow Statement Financials | |
$-13.52M |
|
$-0.04M |
|
$14.81M |
|
$118.04M |
|
$119.28M |
|
$1.24M |
|
$5.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.18% |
|
-14.65% |
|
-12.59% |
|
-14.18% |
|
$1.76 |
|
$-0.20 |
|
$-0.20 |
|